| Literature DB >> 2892823 |
T Tsuruo1, Y Sugimoto, H Hamada, I Roninson, M Okumura, K Adachi, Y Morishima, R Ohno.
Abstract
We have examined the expression of P-glycoprotein in clinical leukemic cell samples by using a monoclonal antibody (MRK16) against P-glycoprotein. We found that leukemia cells isolated from 3 out of 6 patients with blast crisis of chronic myelogenous leukemia were reactive to MRK16. These 3 cell lines expressed high levels of mdr1 mRNA, which codes for P-glycoprotein. The present result indicates that the clinically refractory state of the tumor may be predicted in part by determining P-glycoprotein expression using the monoclonal antibody against P-glycoprotein, and the mdr1 probe.Entities:
Mesh：
Substances：
Year: 1987 PMID： 2892823
Source DB: PubMed Journal: Jpn J Cancer Res ISSN： 0910-5050